You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
安科生物(300009.SZ):與阿法納簽署新型冠狀病毒突變株mRNA疫苗研究戰略合作框架協議
格隆匯 04-13 20:49

格隆匯4月13日丨安科生物(300009.SZ)公佈,為積極響應和滿足當前新冠疫情防控的需求,進一步豐富公司研發管線、完善公司技術研發創新體系,持續提升公司在生物醫藥領域的核心競爭力和行業地位,安徽安科生物工程(集團)股份有限公司(“乙方”)近日與合肥阿法納生物科技有限公司(簡稱“阿法納”或“甲方”)簽署了《戰略合作框架協議》,雙方建立戰略合作伙伴關係,充分發揮各自優勢,就阿法納開發的“新冠奧密克戎等突變株mRNA疫苗”的臨牀前研究、臨牀研究、產業化及市場銷售等方面開展排他性合作。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account